INTRODUCTION

The morphological correlates of schizophrenia are subtle, and range from a slight reduction in brain size to localized alterations in the morphology and molecular composition of specific neuronal, synaptic, and glial populations in several brain regions (Harrison and Weinberger, 2005). An increasing body of evidence from neuroimaging and post-mortem studies also suggests that structural connectivity between brain regions is disturbed in schizophrenia and that altered myelination may—in part—account for this deficit (Konrad and Winterer, 2008). In particular, the frequently made observation in functional imaging and electrophysiological studies that left frontotemporal connectivity might be preferentially affected in schizophrenic patients and their relatives has recently obtained support from several microstructural imaging studies (Konrad and Winterer, 2008; Szeszko et al, 2008). However, it is currently unknown what molecular mechanisms may account for the deficiency of structural connectivity in schizophrenia illness.

The notion that axonal myelination might be affected in schizophrenia is currently supported by post-mortem studies which have identified abnormalities in the myelin sheath (Uranova et al, 2001) and oligodendroglia (Hof et al, 2003). Decreased expression of several myelination-related genes in patients further supports the hypothesis of white matter (WM) abnormalities (Hakak et al, 2001). Indirect evidence also comes from recent genetic association studies involving an abnormal Neuregulin 1 (NRG1)–ErbB4 signaling pathway in risk for schizophrenia illness. NRG1 is involved in neural development, synapse formation, and synaptic plasticity by activating ErbB receptor tyrosine kinases (Anton et al, 2004; Liu et al, 2007; Thompson et al, 2007) but it has also been demonstrated to modulate myelination by regulating oligodendrocyte proliferation, differentiation, and myelination (Corfas et al, 2004; Taveggia et al, 2008). Among the ErbB proteins, ErbB4 is the best characterized for its functions in the CNS. ErbB4 isoforms exhibit distinct tissue-specific and brain-region-specific patterns of expression (Mei and Xiong, 2008). For example, it has been demonstrated that the thalamocortical axon projection is regulated by NRG1 and ErbB4 (Lopez-Bendito et al, 2006).

The NRG-1 is now thought of being one of the prime susceptibility genes for schizophrenia (Harrison and Law, 2006; Munafo et al, 2008). Among the ErbB receptor genes, ErbB4 is of particular interest and it has been chosen for analysis in this study because its coding gene ErbB4 has been reported to be a risk gene for schizophrenia illness. The ErbB4 gene spans 1.16 Mb on chromosome 2q34, consists of 28 exons and encodes one of the four members of the mammalian ErbB family of transmembrane tyrosine kinases (Fox and Kornblum, 2005). To date, no coding mutations have been identified in the ErbB4 gene and all reported schizophrenia-associated risk single-nucleotide polymorphisms (SNPs) are noncoding intronic variants (Law et al, 2007). Law et al suggested that the risk ErbB4 SNPs may be functional through splicing regulation or may monitor functional elements within the gene associated with schizophrenia risk. A significant association with schizophrenia was shown in a large sample (N=296) of schizophrenia families and control individuals (N=370) for two three-SNPs ErbB4 haplotypes, one including rs7598440, rs839541, and rs839523 around exon 3 (Nicodemus et al, 2006). For this latter haplotype, the same group was able to confirm their findings in a sample of African-American families (Nicodemus et al, 2006). Moreover, another association study of unrelated Ashkenazi schizophrenia patients (N=59) and matched controls (N=130) found similar results showing significant associations with 3 out of 19 SNPs along the ErbB4 gene from one linkage disequilibrium (LD) block: rs707284, rs839523, and rs7598440 (Silberberg et al, 2006). In addition, Silberberg et al (2006) reported that a schizophrenia risk haplotype around exon 3 (SNPs rs839523, rs707284, and rs7598440) is associated with altered expression of certain splice variants of the gene (CYT-1 isoform) in schizophrenia brain. This finding was confirmed by Law et al (2007) who found main effects for rs839523 as well as for rs707284, rs7598440, and a core-risk haplotype surrounding exon 3 on expression of the exon 26 (CYT-1) variant isoform of ErbB4 mRNA in hippocampus and dorsolateral prefrontal cortex. It has therefore been suggested that NRG1 may mediate its effects on schizophrenia susceptibility through functional interaction with ErbB4, and that genetic interaction between variants at the two loci together increases the genetic risk for schizophrenia (Norton et al, 2006). Norton et al examined 15 SNPs, revealed by mutation screening in schizophrenic patients, although evidence for association was shown for only 1 marker (rs7424835). Taken together, only a small number of ErbB4 association studies have been performed and some of the findings are controversial.

Two recent diffusion tensor imaging (DTI) studies have reported schizophrenia risk NRG1 genotype effects on WM microstructure in human brain (McIntosh et al, 2007; Winterer et al, 2008). These studies thus support the notion that variations of the NRG1 gene might indeed be relevant for neuronal myelination as fractional anisotropy (FA) is thought to be an index of the degree of neuronal myelination (Davis et al, 2003). In the present DTI study of young healthy Caucasian subjects (N=59), we tested whether the previously identified schizophrenia risk SNPs from the haplotype around exon 3 of the ErbB4 gene are associated with FA. The scientific rationale of this study was that neuroimaging studies may help to elucidate the neurobiological mechanisms through which particular genes exert their effect on human brain. In addition, when endophenotypes (eg brain imaging measures) are used, it is expected that a gene effect, ie the effect size, is increased as compared to the effect on clinical phenotypes because biological phenotypes are thought to be closer to the genetic level (Winterer et al, 2005). Currently, a minimum sample size of N=50 is thought to be sufficient for genetic analyses of structural brain images, depending on the allele frequency (van Haren et al, 2008). For example, Szeszko et al (2005) examined the effect of the brain-derived neurotrophic factor val66met on hippocampal structural alterations in 44 subjects comparing N=27 val/val homozygotes with N=17 val/met heterozygotes. Zinkstok et al (2008) investigated whether variations in the catechol-O-methyltransferase gene are associated with brain anatomy in a sample of male schizophrenic patients of N=51 (genotype group sizes between 9 and 39 patients).

We investigated exclusively healthy subjects because it has been shown that antipsychotic drugs differentially regulate the expression of NRG1 and ErbB4 receptors in rat brain (Wang et al, 2008) and because prior studies have reported an association between FA and antipsychotic treatment (Minami et al, 2003; Eto et al, 2006; Kuroki et al, 2006) which both suggests that any investigation of ErbB4 gene effects on brain structure could potentially be confounded by drug effects in schizophrenic patients. Moreover, schizophrenia is a complex polygenic disorder whereby each of multiple gene variations that are common in the general population is thought to contribute only a minor fraction to the overall risk (Harrison and Weinberger, 2005). Therefore, the effects of specific risk gene variations on brain structure can be investigated in the general population as well, ie in healthy subjects—even in the absence of overt behavioral abnormalities seen in patients—provided the employed phenotypic measure is related to the genetic risk for schizophrenia and that it is sensitive enough to detect genetic effects (Winterer et al, 2005). Therefore, our approach to investigate healthy subjects offers some advantages although it does not allow to study the interaction between the gene variation of interest and any other illness-related factors such as structural changes during the course of the illness or psychopathological characteristics. As part of our study, we also conducted a voxel-based morphometry (VBM) analysis in order to determine whether any observed FA genotype group differences are possibly due to indirect effects of brain volume differences. In order to assess the functional relevance of any given association, we also measured reaction time (RT) during oddball task conditions, which is a frequently applied endophenotype of selective attention/working memory to detect abnormal left frontotemporoparietal brain activation in subjects at risk for schizophrenia (Winterer et al, 2003; Javitt et al, 2008).

METHODS

Subjects

Healthy subjects (N=59; mean age 22.6±1.8 years) were investigated (Table 1). Only unrelated Caucasian subjects were included in the study. Participants were only investigated if there was no evidence for any medical or neurological condition that could interfere with the purpose of the study, or if there was no history for any psychiatric DSM-IV axis I or axis II disorder including current or recent drug or alcohol abuse as assessed by a Structured Clinical Interview (First et al, 1995), a formal medical and neurological examination including urine toxicology for illegal drug abuse screening, routine blood tests, an urine investigation and a clinical EEG session. None of the investigated subject had family histories of schizophrenia or bipolar disorder. All subjects were right-handed. No statistically significant differences (P<0.05) between genotype groups (rs839523, rs7598440, rs839541, rs707284) were found with regard to age and sex and intelligence quotient (IQ). IQ was assessed with the HAWIE-R (Hamburg-Wechsler Intelligenztest) Scale (Tewes, 1991), which is largely equivalent with the full-scale Wechsler Adult Intelligence Scale-R (Kaplan et al, 1991). Only subjects with an IQ >80 were included in the study. Written informed consent was obtained from all study participants. The study was approved by the Ethics Committee of the Johannes Gutenberg University in Mainz (Germany).

Table 1 Demographic and Behavioral Data by Genotype Group rs839523

Image Acquisition

Magnetic resonance imaging (MRI) scanning was performed with a 1.5 T Siemens Sonata® system at the Institute of Neuroradiology of the Johannes Gutenberg University, Mainz, Germany. An eight-channel head coil was used. Head movements were minimized by tightly fixating the head with cushions during the scanning procedure. After a localizer sequence for orientation, a high-resolution T1-weighted MRI volume data set was acquired using a magnetization-prepared rapid gradient echo (MP-RAGE) sequence. The acquisition matrix was 256 × 256, 176 slices were acquired with 1 mm slice thickness and a 15° flip angle. Repetition time (TR) was 2860 ms, echo time (TE) was 3.9 ms.

DTI was conducted with echo-planar-imaging sequences. The images were acquired in six noncollinear diffusion-sensitizing gradient directions with diffusion sensitivity b=1000 mm2/s and one acquisition without diffusion encoding (b=0 mm2/s). A generalized autocalibrating partially parallel acquisition reconstruction algorithm was used. Slices were positioned along the anterior commissure–posterior commissure line. The diffusion acquisition parameters were as follows: the acquisition matrix was 128 × 128 with a field of view of 192 × 192 mm and a resolution of 1.5 × 1.5 × 2.0 mm3. Slice thickness was 2 mm and 64 axial slices were acquired to cover the whole brain without interslice gap. Other parameters were: TR=8000 ms, TE=100 ms. A total of 10 acquisitions were performed and averaged, the total duration of the DTI measurement was 20 min.

Image Preprocessing

All scans were inspected visually. T1-weighted images from 8 subjects and DTI series from 9 subjects were excluded (due to gross motion artifacts or due to technical problems), DTI data sets from 50 subjects (Table 1) and T1 data sets from 51 subjects were included. Original MR diffusion, T1- and T2-weighted images were registered in DICOM format and converted to ANALYZE format using MRIcro software (University of Nottingham, UK).

Diffusion Tensor Imaging Analysis

The T2-weighted images were normalized to the MNI (Montreal Neurological Institute) T2 template using SPM2 (statistical parametric mapping; Wellcome Department of Cognitive Neurology, London, UK) software implemented in MatLab 6.5 (Mathworks Inc., Sherborn, MA, USA). Identical normalization parameters were used for warping of the diffusion-weighted images such that each voxel represents the same part of the brain in every subject. For the calculation of FA maps, the FDT tool (FMRIB's diffusion toolbox) of the FSL software library (FMRIB's software library) was used. The obtained FA maps were then smoothed with a 6 × 6 × 6 mm FWHM Gaussian kernel to improve signal-to-noise ratio and normalization. The choice of using a 6 mm filter was based on evidence from imaging studies that the smoothing filter should be at least 2–3 times larger than the voxel size. Voxel-based FA contrast analysis was then done to compare genotype groups using general linear model (GLM) standard two sample unpaired t-test. Following established procedures (Shin et al, 2005; Szeszko et al, 2008), contrast maps were thresholded at a P<0.001 without correction for multiple comparisons and the extent threshold for significant clusters was set to 40 voxels.

We prepared an FA template according to the procedure described by Smith et al (2006), which was then overlaid with the statistically significant SPM clusters using MRIcro software for graphical presentation in neurological convention (R=R). The MRI atlas of human WM (Mori et al, 2005) was used for the identification of subcortical WM structures. The t-statistic of the peak voxel cluster, the cluster size, and the corresponding Brodman area and anatomical structures were determined (Mori et al, 2005). The MNI coordinates of the most significant voxel from the contrast analysis was used to calculate the mean FA values in the most significant ‘peak voxel’ together with six adjacent voxels in each subjects data set. This data were used to depict data in a scatterplot.

Voxel-based Morphometry Analysis

Voxel-based morphometry was carried out with an optimized VBM protocol (Ashburner and Friston, 2000) using SPM5 software implemented in MatLab 7.1. The high-resolution T1-weighted MRI data sets were first normalized to a standard template. The procedure then perfomed segmentation of the normalized images into gray matter (GM), WM, and cerebrospinal fluid (CSF). The segmented images were then smoothed with a 6 mm FWHM kernel. Voxel-wise comparisons of the normalized, segmented, and smoothed data were then performed between genotype groups with two contrasts (two sample unpaired t-test) to test for significant differences of local brain tissue concentration and volume.

Biological Parametric Mapping

Biological parametric mapping (BPM) combines information from different imaging modalities on a voxel-wise basis using the GLM (Casanova et al, 2007). After voxel-wise integration of imaging parameters, each voxel has a unique regression design that includes the value of each imaging modality for the voxel. In order to rule out important confounding genotype group differences in VBM measures and their effect on FA analyses in our data set, the analysis takes into account, separately for each voxel, the effect of a covariate image (VBM) on the image of interest (FA map).

The BMP toolbox (www.ansir.wfubmc.edu) is integrated in MatLab, the analysis was performed as described in detail by Casanova et al (2007). The resulting T maps generated in the BPM program were then exported to the SPM5 environment where they were thresholded at a P<0.001 (uncorrected) and overlaid on FA templates for graphical presentation of significant genotype group differences.

Oddball Task

To assess neurocognitive function, we measured RT during a visual oddball task as RT during oddball task conditions is known to be prolonged in schizophrenia patients while being associated with the degree of activation in frontotemporopariatal brain circuits (Frodl et al, 1998; Gur et al, 2007). Intraindividual RT variability, which reflects short-term fluctuations in performance, was also measured because it was reported to be increased in patients with schizophrenia and because it was suggested to be a sensitive marker for the efficiency of top-down attentional control (Kaiser et al, 2008). Subjects were required to perform the oddball task right before the image acquisition. A total of 160 visual stimuli (40 targets, 120 nontargets, checkerboard reversal) were presented by means of a back-projection system onto a translucent screen using the ‘Presentation’ software package (Neurobehavioral Systems Inc.). Subjects were instructed to respond as quickly and accurate as possible to each stimulus (checkerboard) by pressing either the left button (nontarget) or the right button (target) with their index fingers. Stimuli were presented with a duration of 500 ms in counter-balanced and pseudo-randomized order at ‘jittered’ interstimulus intervals of 6000±500 ms between stimulus onsets, the total duration of the task was 960 s. Motor responses (latencies) were recorded through a fiber optic response box.

Genotyping

DNA was obtained from venous blood using standard techniques. Four SNPs (rs7598440, rs839541, rs839523, and rs707284) from the ErbB4 gene around exon 3 (Figure 1)—that have been previously associated with schizophrenia (Nicodemus et al, 2006; Silberberg et al, 2006; Law et al, 2007)—were genotyped by the analysis of primer extension products generated from amplified genomic DNA using a Sequenom (San Diego, California) chip-based MALDI-TOF mass spectrometry platform. In brief, polymerase chain reaction (PCR) and extension reactions were designed using MassARRAY design software, and were carried out using 2.5 ng of template DNA. Unincorporated nucleotides in the PCR product were deactivated using shrimp alkaline phosphatase. The primer extension products were then cleaned and spotted onto a SpectroChip with a massARRAY nanodispenser. The chips were scanned using a mass spectrometry workstation (MassARRAY compact analyzer; Sequenom) and the resulting spectra were analyzed and genotypes were determined using the Sequenom SpectroTYPER-RT software.

Figure 1
figure 1

ErbB4 gene. (Top) ErbB4 gene with positions (bp) of reported single-nucleotide polymorphism (SNPs; Ensembl Genome Browser, www.ensembl.org). (Bottom) Linkage disequilibrium (LD) plot (r2 values) for the four investigated SNPs in the present study in N=59 subjects. (haploview version 3.32) (Barrett et al, 2005).

Statistics

Statistical analyses were conducted with Student's t-tests, Mann–Whitney U-tests or regression analysis as appropriate. As the FA values of the peak voxels were not normally distributed, we adopted Mann–Whitney U-tests for genotype group comparison. The ratio of explained variance of FA attributable to genotype to total variance was calculated as the ratio of the explained sum of squares to the total sum of squares. Tests for Hardy–Weinberg equilibrium (HWE), LD plots and pairwise LD values were calculated with the program haploview version 3.32 (Barrett et al, 2005).

To further increase statistical power, we combined the smaller homozygous genotype group with the heterozygous group depending on genotype distribution. An analogous procedure was chosen for analyzing haplotype effects. Sample sizes were too small to assess the putative modes of transmission. It is worth mentioning that the mode of transmission of schizophrenia risk conferring effects is unknown (Nicodemus et al, 2006; Silberberg et al, 2006).

RESULTS

Genotype Distribution

Allele frequencies of the four ErbB4 SNPs were similar to what has been reported previously (Nicodemus et al, 2006; Silberberg et al, 2006) and no significant deviations (P<0.05) from HWE were observed (Table 2). LD analysis between SNPs (Figure 1) showed high LD between the haplotype SNPs (rs7598440, rs839541, rs839523, and rs707284) which all have been reported to be associated with schizophrenia illness (Nicodemus et al, 2006; Silberberg et al, 2006; Law et al, 2007). For further analyses, we selected SNP rs839523 because it is tagging the schizophrenia risk haplotype block (Nicodemus et al, 2006; Silberberg et al, 2006) and because it was reported to show the highest association with schizophrenia of all investigated ErbB4 SNPs (Silberberg et al, 2006).

Table 2 Genotype Groups and Minor Allele Frequencies

Subject Parameters

For all haplotype SNPs (rs7598440, rs839541, rs839523, and rs707284), we found no statistically significant differences (P>0.05) between genotype groups (G/G vs [A/G+A/A]) with regard to age, sex, education, and general intelligence (IQ)—neither in the VBM nor for the DTI sample (Table 1).

SNP Genotype Effects on Structural Image Parameters

Voxel-wise parametric FA contrast analyses of genotype groups revealed statistically significant group differences (thresholded at P<0.001, uncorrected) for SNP rs839523 (Figures 2 and 3) with a maximum in the left temporal lobe WM (peak MNI coordinates −50, −18, −12; t=4.73, cluster size=271 voxels) and in the right temporal lobe WM (52, −4, −10; t=3.94, 62 voxels). In people homozygous for the schizophrenia risk allele (G), FA was found to be significantly lower. The percentage of the variance in FA in the left temporal peak cluster that is attributable to genotype was 30.0%. In the left temporal WM region, where the genotype-dependent peak maximum FA differences were observed, portions of several association tracts are closely aligned: inferior longitudinal fasciculus and superior longitudinal fasciculus and—in particular—a large part of two left frontotemporal connections, ie the inferior frontooccipital fasciculus (IFO) and uncinate fasciculus (Mori et al, 2005).

Figure 2
figure 2

rs839523 genotype group effects (G/G vs A/G+A/A) on fractional anisotropy. (Top) Voxel-wise t-statistic genotype group FA contrast map overlaid on FA template on axial slices. Peak cluster in left temporal white matter (WM) (Montreal Neurological Institute, MNI coordinates, x y z: −50 −18 −12). Color scaling with t-value range from t=1.68 to tmax=4.73. (Bottom) Voxel-wise covariate approach (Biological parametric mapping), which takes into account the effect of the VBM covariate image on the FA image of interest. Peak cluster in left temporal WM (MNI –coordinates, x y z: −50 −18 −12). Color scaling with t-value range from t=1.68 to tmax=5.0. Notably, FA genotype effects in left frontotemporal connections are more prominent when accounting for VBM measures. Images are represented in neurological convention (R=R). Given are the MNI z coordinates for each slice. FA, fractional anisotropy; BPM, biological parametric mapping; VBM, voxel-based morphometry.

Figure 3
figure 3

Scatterplots for rs839523 genotype group comparison (G/G vs [G/A+A/A]). (Left) rs839523 genotype group comparison of each subject's mean value (N=50) of fractional anisotropy (FA) in the ‘peak voxel’ together with six adjacent voxels in each direction. Genotype group differences are statistically significant (Mann–Whitney U-test, Z=−4.31, P=1.63 × 10−5). Arrows indicate A/A genotype carriers. (Middle) rs839523 genotype group comparison of each subject's mean reaction time (RT). Genotype group differences are statistically significant (Mann–Whitney U-test, Z=−2.19, P=0.029). (Right) rs839523 genotype group comparison of each subject's RT intrasubject variability. Genotype group differences are statistically significant (Mann–Whitney U-test, Z=−2.51, P=0.012).

In the context of the main hypothesis, we performed an additional analysis of genotype effects on FA and regional brain volume for the other three SNPs (rs7598440, rs839541, and rs707284) of the risk haplotype around exon 3. Essentially identical results were found compared to rs839523 (Table 3). This was not unexpected given that the group compositions were largely similar because of the relatively high LDs between those three SNPs and rs839523 (Figure 1). As the selected SNPs were not independent because of the high LDs, we did not perform a Bonferroni correction for multiple testing. VBM analysis in all haplotype SNPs did not reveal any effects on regional brain volume (not depicted).

Table 3 Genotype Effects of SNPs and Haplotypes on Fractional Anisotropy

Voxel-based Morphometry and Biological Parametric Mapping

VBM parametric contrast analyses of the two SNP rs839523 genotype groups did not demonstrate any significant regional brain volume differences in the particular brain region or any other area in WM, GM, and CSF (thresholded at P<0.001, uncorrected).

The additional BPM voxel-wise covariate approach was performed for SNP rs839523 genotype groups to rule out important changes in VBM measures that failed to reach significance at the P<0.001 level. The results of this FA analysis demonstrate the essentially identical peak cluster in the left temporal lobe WM when accounting for VBM measures (peak MNI coordinates −50, −18, −12; t=5.04, cluster size=192 voxels; Figure 2). In addition, a significant cluster with FA reduction in the GG genotype group was located in frontotemporal connections, corresponding to sections of the IFO and the uncinate fasciculus (peak MNI coordinates −34, 14, 4; t=3.77, cluster size=57 voxels; Figure 2). Though, no significant cluster in the right hemisphere was found in the BPM covariate analysis of FA maps.

Split Half Analysis for rs839523

Testing for the stability of the obtained results, two randomly selected subgroups (split halves) of the rs839523 genotype group were used for two separate group analyses. In both subgroups, we found the following genotype effects in left temporal WM: for the first subgroup (N=25), peak MNI coordinates were −56, −16, −8; t=3.99 with cluster size=51 voxels. The corresponding values for the second subgroup (N=25) were: −52, −20, −10; t=3.88, and cluster size=13 voxels. The peak cluster in both subgroups was located within the significant cluster of the entire sample, but it has to be mentioned that the peak cluster in the second subgroup was below the minimal cluster size of 40 voxels.

Haplotype Effects on Structural Image Parameters

In addition, we performed an analysis for the risk haplotype rs707284-rs758440-rs839523-rs839541 (G-T-G-T) comparing people homozygous for all four risk alleles (N=18) with persons who were not homozygous for any of the risk alleles (N=14). Largely identical results to the above-mentioned single SNP analyses were found (Table 3). VBM analysis for haplotype effects did not reveal any effects on regional brain volume (not depicted).

Genotype Effects on Reaction Time

We observed a significant rs839523 genotype effect on RT (Mann–Whitney U-test: Z=−2.19, P=0.029) and intraindividual RT variability (Mann–Whitney U-test: Z=−2.51, P=0.012; Table 1; Figure 3). Mean RT and RT variability were significantly higher in the homozygous risk allele (G/G) group (539±56 ms) than in the combined heterozygous (A/G) and homozygous (A/A) group (497±45 ms). As expected, the task-related error rate did not differ significantly between groups, as it was very low (=0.01) in both groups.

Correlation of FA and RT/RT Variability

Notably, individual FA values in the seven-voxel peak cluster in the left temporal WM were found to correlate with neurocognitive performance. Peak FA values were significantly correlated with RT (r=−0.44, P=0.0036) and with RT variability (r=0.38, P=0.015; Figure 4).

Figure 4
figure 4

Regression analysis (left) between fractional anisotropy (FA) in the seven-voxel peak cluster in left temporal white matter (WM) and mean reaction time (Spearman's correlation coefficient r=−0.44, P=0.0036). Regression analysis (right) between FA in the seven-voxel peak cluster in left temporal WM and reaction time intrasubject variability (Spearman's correlation coefficient r=−0.38, P=0.015).

DISCUSSION

This is the first study suggesting that the ErbB4 gene affects subcortical microstructure in humans. Specifically, we found that subjects homozygous for the schizophrenia risk G allele of SNP rs839523 (Nicodemus et al, 2006; Silberberg et al, 2006; Addington et al, 2007; Law et al, 2007) show decreased FA in the left temporal lobe WM—a brain region which contains frontotemporal fiber tracts but also fiber bundles that connect the parietooccipital and frontal cortex (Mori et al, 2005). SNP rs839523 was selected as a tagging SNP for the schizophrenia risk haplotype block, showing the highest association with schizophrenia of all investigated ErbB4 SNPs in the study of Silberberg et al (2006). Notably, abnormal activation and functional connectivity in left frontotemporoparietal brain regions is a well-known finding in schizophrenia patients and their relatives (Winterer et al, 2003). Accordingly, our findings may suggest that these functional deficits might be caused to some extent by structural variations of fiber tracts in this particular brain region involving the ErbB4 gene. It is therefore of interest that the functional relevance of ErbB4—via its possible impact on the structural integrity of these fiber tracts—is further supported, ie externally validated, by our additional finding that FA was also related to RT which itself is frequently impaired in schizophrenia and which has been proposed to be an endophenotype of schizophrenia (Filbey et al, 2008). In this context, it is worth mentioning that several earlier studies have linked poor neurocognitive performance with reduced FA in frontotemporal fiber tracts (Szeszko et al, 2008). At the same time, our finding that the schizophrenia risk genotype predicts RT in the expected direction largely concurs with another study, which has reported ErbB4 genotype effects on neurocognitive measures in healthy controls (Nicodemus et al, 2006). The impact of schizophrenia risk NRG1 genotypes on human WM has been shown in two DTI studies (McIntosh et al, 2007; Winterer et al, 2008). Therefore, our findings provide additional support for the notion that variations of the NRG1/ErbB4 signaling pathway might indeed be relevant for neuronal myelination. McIntosh et al (2007) demonstrated an effect of the SNP8NRG243177 genotype on the anterior limb of the internal capsule, whereas our group showed effects of the SNP8NRG221533 genotype from the same risk haplotype on medial frontal WM (Winterer et al, 2008). Abnormalities in these WM structures, as well as in frontotemporal fiber tracts, in schizophrenia have been shown in several DTI studies (Konrad and Winterer, 2008). Though, the impact of different NRG1/ErbB4 risk genotypes on different WM regions is currently difficult to interpret.

FA has been suggested to be a parameter for WM integrity but the biological determinants are not yet entirely understood (Schmithorst et al, 2008). However, an increase of FA has been found under nonpathological conditions during developmental myelination (Huppi and Dubois, 2006) and decreased FA values are well known in pathological conditions which impair myelination (Filippi et al, 2001). Even so, there is also evidence that the number and density of axon fibers and the coherence of these fibers influence FA (Papadakis et al, 1999). Thus, although it is intriguing to interpret our finding in a way such that the ErbB4 effect on FA and—by extension on RT—is due to an effect on neuronal myelination, other possibilities cannot be excluded with certainty at this point. Theoretically, it is also conceivable that indirect downstream effects on WM axon fibers, which may result—for instance—from gene-dependent abnormal synaptic input, account for our finding (Konrad and Winterer, 2008). In fact, this possibility does not appear entirely unlikely given that in animal brains, an ubiquitous expression of ErbB receptors has been demonstrated indicating that a variety of cell populations throughout the brain have the potential to respond to neuregulins in different ways. For example, Thompson et al (2007) reported that in frontal primate cortex, ErbB2, ErbB3, and ErbB4 antibodies immunostained neuronal soma and nuclei, the ErbB2 antibody also immunostained glia at the pial surface. Chong et al (2008) found that ErbB4 protein levels were significantly increased in prefrontal cortical cytoplasmic and nuclear fractions of schizophrenic patients relative to normal and to depressed subjects. On the other hand, ErbB3 and ErbB4 proteins were also localized to putative interstitial WM neurons whereas ErbB2 protein was found in glia. Roy et al (2007) recently reported of transgenic mice in which ErbB signaling was blocked in oligodendrocytes in vivo. They found that loss of all ErbB signaling (including ErbB2, 3 and 4) leads to changes in oligodendrocyte number and morphology, reduced myelin thickness, and slower conduction velocity in axons of central neurons. Others reported embryonic lethality in ErbB4 mouse mutants (Schmucker et al, 2003) and disturbed glial cell differentiation in ErbB4 knockout mice (Sardi et al, 2006). Thus, if the notion were correct that ErbB4 exerts its impact on FA via myelination, one might conclude that genetic susceptibility for schizophrenia via the ErbB4 gene could be mediated through the effect on neuronal myelination in frontotemporoparietal fiber tracts. In this context, a study of altered splice-variant expression in brain regions of schizophrenia patients is of particular interest: Law et al (2007) provided a direct link between disease-associated genetic variation including rs839523 and ErbB4 splice-variant mRNA expression levels in the human brain.

As expected and observed in many other genetic neuroimaging studies, the observed gene effect is subtle. It was, however, less expected that the observed gene effect is relatively circumscribed and limited to the left temporal region. This is because structural and functional imaging studies tend to find more widespread connectivity abnormalities in schizophrenia although most consistently in the left frontotemporal brain area. One might speculate that this region is particularly vulnerable to genetic variations during developmental myelination. A possible explanation could be that the age-dependent trajectory of myelination is dependent on ErbB4 genotype in this area due to the delayed and persistent myelination into the third decade of life in frontotemporal but not occipitoparietal fiber tracts (Yakovlev and Lecours, 1967; Paus et al, 1999), which indicates that oligodendrocyte regulation differs regionally. To some extent in line with notion idea would be the finding of Addington et al (2007) who observed in their longitudinal study of young schizophrenic patients that NRG1 risk allele carriers had different trajectories of change in brain lobar volumes, ie greater total GM and WM volume in childhood and a steeper rate of subsequent decline in volume into adolescence. Though, from the results of the current study, we are not able to suggest a developmental time point for the described effects on the brain structure.

Taken together, the findings of the present study indicate that ErbB4 gene variations may contribute its part to disturbed left frontotemporal connectivity in schizophrenia illness—possibly via an effect on myelination. The gene effect of a single risk SNP (rs839523) or haplotype, however, may play only a small role in total illness predisposition. Further replication studies—also involving clinical samples—are needed to confirm the results in our sample and to improve our understanding of the biological effects of the NRG1–Er6B4 signaling cascade in human brain.